Pharma firm share placing aims to raise over £18m

18 February 2020 – TheBusinessDesk

4D pharma is a listed Leeds-based pharmaceutical company. The company has launched a proposed fundraising by way of a placing and subscription of new ordinary shares and warrants to raise proceeds of at least £18m.

Net proceeds of the fundraising, together with the company’s existing resources, will go towards supporting its ongoing clinical studies into Irritable Bowel Syndrome (IBS) and oncology and enable 4D pharma to continue to fund its operations for at least two clinical study readouts, as well as for general corporate purposes.


%d bloggers like this: